Evaluation of Real-world Efficacy of Mepolizumab on SNOT-22 Outcomes in Patients with Unified Airway Disease
Overview
Overview
Journal
Clin Transl Allergy
Publisher
Wiley
Specialty
Allergy & Immunology
Date
2024 Nov 1
PMID
39482847
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Gonzalez-Perez R, Poza-Guedes P, Martin-Voso M, Sanchez-Machin I Clin Transl Allergy. 2024; 14(11):e70006.
PMID: 39482847 PMC: 11527812. DOI: 10.1002/clt2.70006.
References
1.
Phillips K, Hoehle L, Caradonna D, Gray S, Sedaghat A
. Minimal clinically important difference for the 22-item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol. 2018; 43(5):1328-1334.
DOI: 10.1111/coa.13177.
View
2.
Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S
. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020; 58(Suppl S29):1-464.
DOI: 10.4193/Rhin20.600.
View
3.
Bachert C, Luong A, Gevaert P, Mullol J, Smith S, Silver J
. The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic Therapy. J Allergy Clin Immunol Pract. 2023; 11(9):2630-2641.
DOI: 10.1016/j.jaip.2023.05.011.
View
4.
Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado C, Colodenco F, Giavina-Bianchi P
. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022; 8(3).
PMC: 9339769.
DOI: 10.1183/23120541.00576-2021.
View
5.
Gonzalez-Perez R, Poza-Guedes P, Martin-Voso M, Sanchez-Machin I
. Evaluation of real-world efficacy of mepolizumab on SNOT-22 outcomes in patients with unified airway disease. Clin Transl Allergy. 2024; 14(11):e70006.
PMC: 11527812.
DOI: 10.1002/clt2.70006.
View